onytec 80 mg/g medicinsk neglelak
orifarm a/s - ciclopirox - medicinsk neglelak - 80 mg/g
onytec 80 mg/g medicinsk neglelak
paranova danmark a/s - ciclopirox - medicinsk neglelak - 80 mg/g
idefirix
hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - immunosuppressiva - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.
fentanyl carefarm 12 mikrogram/time depotplastre
orifarm a/s - fentanyl - depotplastre - 12 mikrogram/time
bridion
merck sharp & dohme b.v. - sugammadex - neuromuskulær blokade - alle andre terapeutiske produkter - tilbagevendelse af neuromuskulær blokade induceret af rocuronium eller vecuronium. for peadiatric befolkning: sugammadex er kun anbefales til rutinemæssig tilbageførsel af rocuronium-induceret blokade i børn og unge.
sugammadex "hameln" 100 mg/ml injektionsvæske, opløsning
hameln pharma gmbh - sugammadexnatrium - injektionsvæske, opløsning - 100 mg/ml
sugammadex mylan
mylan ireland limited - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex "teva" 100 mg/ml injektionsvæske, opløsning
teva b.v. - sugammadexnatrium - injektionsvæske, opløsning - 100 mg/ml
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex "noridem" 100 mg/ml injektionsvæske, opløsning
noridem enterprises ltd. - sugammadexnatrium - injektionsvæske, opløsning - 100 mg/ml